Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
NCT00736060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2011-08-26
Summary
This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.
Conditions
- Sickle Cell Anemia
- Sickle Cell Thalassemia
Interventions
- OTHER
-
Observational
Summary of clinical and laboratory data
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Carina Levin, MD · Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
-
Ilena Arshinov, MD · Pediatric Dpt B - Ha'Emek Medical Center - Afula - Israel
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Completion
- 2008-11-30
Countries
- Israel
Study Locations
More Related Trials
-
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512226 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Anemia Screening and Prevention in Northern Israel
NCT00735488 ·Status: COMPLETED
-
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
NCT01905787 ·Status: UNKNOWN
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
NCT00481039 ·Status: COMPLETED
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Long Term Follow up in Sickle Cell Patients Treated by Hydroxyurea
NCT00480974 ·Status: COMPLETED
-
Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"
NCT06735625 ·Status: RECRUITING ·Phase: NA
-
The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00971698 ·Status: COMPLETED
-
Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease
NCT07200869 ·Status: NOT_YET_RECRUITING
-
Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study
NCT02090296 ·Status: WITHDRAWN ·Phase: PHASE2
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
NCT06546670 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
NCT03405688 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease
NCT01800526 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
NCT04667325 ·Status: COMPLETED
-
Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia
NCT00972231 ·Status: COMPLETED
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED
-
Microvascular Blood Flow in Sickle Cell Anemia
NCT01566890 ·Status: COMPLETED ·Phase: NA
-
Bone Marrow for Hemoglobinopathy Research
NCT00669305 ·Status: COMPLETED
-
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
NCT04301336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants
NCT06503458 ·Status: TERMINATED
-
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
NCT06609226 ·Status: RECRUITING ·Phase: PHASE3